A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors

Clinical trial NCT07077434 · RECRUITING

Trial details

NCT number: NCT07077434
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-10-15
Primary completion: 2027-01-19
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.